» Articles » PMID: 17875067

A Teaching Hospital's Experience Applying the Pneumonia Severity Index and Antibiotic Guidelines in the Management of Community-acquired Pneumonia

Overview
Journal Respirology
Specialty Pulmonary Medicine
Date 2007 Sep 19
PMID 17875067
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The Pneumonia Severity Index (PSI) was developed to predict mortality in community-acquired pneumonia (CAP). It has been prospectively validated to identify patients who are at low risk of death and thereby aid in the selection of patients for outpatient management. This study assessed the compliance of medical staff at a university teaching hospital with the use of the PSI and the PSI-based local antibiotic guidelines in admitted patients.

Methods: This was a retrospective study of 137 consecutive adults admitted with a primary diagnosis of CAP between July and December 2003. Implementation of the PSI and local antibiotic guidelines occurred 4 months prior to the study period. The data collected included patient demographics, PSI parameters, patient outcomes, adherence and compliance with the PSI scoring process and local antibiotic guidelines.

Results: Forty per cent of all CAP admissions were patients in PSI Class I to III. The compliance with scoring the PSI was low (45 out of 137 patients; 33%), as was the accuracy of the PSI scoring (26 out of 45 patients; 58%). Compliance with the local antibiotic guidelines was 87% in patients in whom the PSI was performed.

Conclusions: In admitted patients, non-adherence with the PSI admission guidelines was common. Compliance with scoring the PSI and its scoring accuracy was low. This may be due to a lack of awareness and its relative complexity. Further studies to identify potential barriers to compliance are warranted.

Citing Articles

Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia.

Quah J, Liew C, Zou L, Koh X, Alsuwaigh R, Narayan V BMJ Open Respir Res. 2021; 8(1).

PMID: 34376402 PMC: 8354266. DOI: 10.1136/bmjresp-2021-001045.


Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study.

Ramirez J, Deck D, Eckburg P, Curran M, Das A, Kirsch C Open Forum Infect Dis. 2021; 8(6):ofab135.

PMID: 34160474 PMC: 8212944. DOI: 10.1093/ofid/ofab135.


Adherence to Guidelines for Assessment and Empiric Antibiotics Recommendations for Community-Acquired Pneumonia at Ambo University Referral Hospital: Prospective Observational Study.

Eticha E, Gemechu W Patient Prefer Adherence. 2021; 15:467-473.

PMID: 33658770 PMC: 7920623. DOI: 10.2147/PPA.S295118.


Development and Implementation of a Clinical Pathway to Reduce Inappropriate Admissions Among Patients with Community-Acquired Pneumonia in a Private Health System in Brazil: An Observational Cohort Study and a Promising Tool for Efficiency....

Moreira R, Mendonca-Filho H, Farias A, Sznejder H, Lang E, Wilson M Open Access Emerg Med. 2020; 12:181-191.

PMID: 32801952 PMC: 7406371. DOI: 10.2147/OAEM.S256220.


Efficacy of quick Sequential Organ Failure Assessment with lactate concentration for predicting mortality in patients with community-acquired pneumonia in the emergency department.

Song H, Moon H, Kim S Clin Exp Emerg Med. 2019; 6(1):1-8.

PMID: 30781940 PMC: 6453698. DOI: 10.15441/ceem.17.262.